Targeting the CD47–SIRPα axis promotes macrophage migration into the tumor mass (14), leading to TAMs being functionally switched from a tumor-promoting M2-like phenotype to a tumoricidal M1-like phenotype and enabling TAMs to attack the tumor. The gene discussed is SIRPA; the disease is neoplasm.